STACKWELL is an adaptive protocol intelligence platform that delivers evidence-based peptide protocols, longevity stacks, recovery systems, and metabolic optimization plans. It combines AI-powered personalization with curated scientific research to help users optimize performance, recovery, and healthspan.

What are peptide protocols?

Peptide protocols are structured regimens using bioactive peptides—such as BPC-157, TB-500, Ipamorelin, or CJC-1295—to support specific biological goals including muscle recovery, fat loss, longevity, hormonal optimization, and skin aesthetics. STACKWELL provides evidence-graded protocols with compound-level explanations and weekly progress tracking.

How does STACKWELL's protocol intelligence work?

STACKWELL's adaptive protocol engine analyzes user goals, experience level, and daily check-in data to recommend and adjust protocols over time. It maps compounds to biological pathways, weighs evidence levels (high, moderate, emerging), and surfaces personalized education matched to your active stack.

What health goals does STACKWELL support?

STACKWELL supports seven primary optimization goals: fat loss, muscle gain, recovery, longevity, energy, libido, and skin aesthetics. Each goal has curated compound stacks, evidence-backed education, and adaptive daily tracking.

BioStack AI helps you optimize biology with personalized protocols, 5 stack tools, community insights, education articles, and tracked adoptions in one app.

Incretin Metabolic Research — fat loss Research Stack

fat losshigh evidence

A comparison of GLP-1-based compounds studied for weight and glucose regulation. These compounds are compared side by side, not combined.

high evidence

An educational collection of compounds commonly researched together. Not a recommendation to use them.

Why These Are Commonly Grouped

All three act on incretin hormone receptors: semaglutide on GLP-1, tirzepatide on GLP-1 and GIP, and retatrutide on GLP-1, GIP and glucagon. They are commonly discussed together to compare mechanisms and clinical trial findings.

Compounds Included

🧬

Semaglutide

📊 Strong EvidenceCaution: Higher

🧬

Tirzepatide

📊 Strong EvidenceCaution: Higher

🧬

Retatrutide

🧪 Emerging ResearchCaution: Higher

Community Discussion

Questions and experiences from members. Community posts are anecdotes, not clinical evidence.

Discuss this Stack

What to Know

high evidence1 weeks ago

Learn more

Commonly discussed for

Weight management, glucose regulation and appetite signaling research.

Uncertainties & interaction considerations

These compounds overlap in mechanism and are not studied in combination. Retatrutide is still investigational. Semaglutide and tirzepatide are prescription medications with known gastrointestinal and other risks.

For educational purposes only. Combining compounds may introduce interactions that have not been studied. STACKWELL does not recommend or prescribe any combination.